Jan 16 (Reuters) – U.S. private equity firm Hellman & Friedman is in early-stage talks for a potential sale of medical devices maker Cordis, seeking a value of over $9 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
About half a dozen publicly traded medical device companies are currently evaluating potential bids for Cordis, the report added.
Hellman & Friedman bought Cordis from Cardinal Health in 2021 for about $1 billion, six years after Johnson & Johnson sold it.
Cordis is known for making cardiovascular devices such as catheters and stents.
H&F and KKR, an investor in Cordis, declined to comment. Cordis did not immediately respond to Reuters’ requests for comment outside of regular business hours.
(Reporting by Carlos Méndez in Mexico City, editing by Chris Reese)
Brought to you by www.srnnews.com